...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Phase 3 BETonMACE Trial is Now Completed. Cognition and CKD Sub-Study Results to be Announced Soon.

Message: Albuminuria

The secondary outcome measures examining change in baseline eGFR did not include urinary albumin measurments  according to clinicaltrials.gov. Unfortunate in my estimation as this is a very relevant parameter to follow in determining CKD progression/regression. Any thoughts?


New Message
Please login to post a reply